Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition-Reference-Cited by-同舟云学术

Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition

Published:2018-06-27 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Jiao Jiantong,Zhang Rui,Li Zheng,Yin Ying,Fang Xiangming,Ding Xiaopeng,Cai Ying,Yang Shudong,Mu Huijun,Zong Da,Chen Yuexin,Zhang Yansong,Zou Jian,Shao Junfei,Huang Zhaohui

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-04936-9.pdf

Reference61 articles.

1. Binder, D. C., Davis, A. A. & Wainwright, D. A. Immunotherapy for cancer in the central nervous system: current and future directions. Oncoimmunology 5, e1082027 (2016).

2. Kohsaka, S. et al. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol. Cancer Ther. 11, 1289–1299 (2012).

3. Kim, E. et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 23, 839–852 (2013).

4. Rahaman, S. O. et al. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21, 8404–8413 (2002).

5. Sherry, M. M., Reeves, A., Wu, J. K. & Cochran, B. H. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 27, 2383–2392 (2009).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIAS3 acts as a zinc sensor under zinc deficiency and plays an important role in myocardial ischemia/reperfusion injury;Free Radical Biology and Medicine;2024-08

2. STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis;BioImpacts;2024-05-11

3. PIAS family in cancer: from basic mechanisms to clinical applications;Frontiers in Oncology;2024-03-25

4. p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme;BMC Cancer;2024-03-07

5. Neovascularization directed by CAVIN1/CCBE1/VEGFC confers TMZ-resistance in glioblastoma;Cancer Letters;2024-02